AU5975700A - Nasal formulation of an antifungal - Google Patents

Nasal formulation of an antifungal

Info

Publication number
AU5975700A
AU5975700A AU59757/00A AU5975700A AU5975700A AU 5975700 A AU5975700 A AU 5975700A AU 59757/00 A AU59757/00 A AU 59757/00A AU 5975700 A AU5975700 A AU 5975700A AU 5975700 A AU5975700 A AU 5975700A
Authority
AU
Australia
Prior art keywords
antifungal
nasal formulation
nasal
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU59757/00A
Inventor
Urbain Alfons Lieven Delaet
Marc Karel Jozef Francois
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of AU5975700A publication Critical patent/AU5975700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
AU59757/00A 1999-07-02 2000-06-20 Nasal formulation of an antifungal Abandoned AU5975700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99202170 1999-07-02
EP99202170 1999-07-02
PCT/EP2000/005679 WO2001001955A1 (en) 1999-07-02 2000-06-20 Nasal formulation of an antifungal

Publications (1)

Publication Number Publication Date
AU5975700A true AU5975700A (en) 2001-01-22

Family

ID=8240408

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59757/00A Abandoned AU5975700A (en) 1999-07-02 2000-06-20 Nasal formulation of an antifungal

Country Status (2)

Country Link
AU (1) AU5975700A (en)
WO (1) WO2001001955A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6824763B2 (en) 2002-05-30 2004-11-30 Kimberly-Clark Worldwide, Inc. Anti-fungal powder having enhanced excipient properties
RU2332997C2 (en) 2004-01-30 2008-09-10 Пфайзер Продактс Инк. ANTIMICROBIAL PRESERVATIVES FOR OBTAINING MULTIDOZE COMPOUNDINGS USING β-CYCLODEXTRINES FOR LIQUID MEDICINAL FORMS
US20070286813A1 (en) * 2006-06-09 2007-12-13 Toutounghi Camille Nasal formulation
WO2009102814A2 (en) * 2008-02-11 2009-08-20 Accentia Biopharmaceuticals, Inc. Mucosally non-irritative liquid amphotericin b formulations and methods for treating non-invasive fungus-induced mucositis
US7635773B2 (en) 2008-04-28 2009-12-22 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions
DK3702374T3 (en) 2012-02-15 2022-06-27 Cydex Pharmaceuticals Inc PROCEDURE FOR MAKING CYCLODEXTRIN DERIVATIVES
EP2909239A4 (en) 2012-10-22 2016-06-08 Cydex Pharmaceuticals Inc Alkylated cyclodextrin compositions and processes for preparing and using the same
CN103251565A (en) * 2013-04-09 2013-08-21 珠海亿邦制药股份有限公司 Voriconazole freeze-dried powder injection for injection and preparation method thereof
PT3183295T (en) 2014-08-22 2023-11-03 Cydex Pharmaceuticals Inc Fractionated alkylated cyclodextrin compositions and processes for preparing and using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346123A1 (en) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse PHARMACEUTICAL PREPARATIONS OF SUBSTANCES MEDICAL OR UNSTABLE IN WATER AND METHOD FOR THE PRODUCTION THEREOF
IT1246188B (en) * 1990-07-27 1994-11-16 Resa Farma PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS HAVING INCREASED SPEED OF DISSOLUTION OF THE ACTIVE SUBSTANCE AND COMPOSITIONS OBTAINED.
US5324718A (en) * 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation
PH31594A (en) * 1993-09-30 1998-11-03 Janssen Pharmaceutica Nv Oral formulations on an antifungal.
GB9711643D0 (en) * 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
IL135774A0 (en) * 1997-10-22 2001-05-20 Ponikau Jens Use of antinfungal agents for the topical treatment of fungus-induced mucositis

Also Published As

Publication number Publication date
WO2001001955A1 (en) 2001-01-11

Similar Documents

Publication Publication Date Title
AU2001227858A1 (en) Delivery of cardiac constraint jacket
AU6310000A (en) Aerosol formulations
AU3243300A (en) Multiparticulate formulation
AU2411100A (en) Humidifier
AU2001286220A1 (en) Preparations for coating wound
AU2001279801A1 (en) Aerosol can
AU758325C (en) Imidazole compounds and medicinal use thereof
AU5286901A (en) Topical anesthetic formulation
AU5037800A (en) Adhesive formulations
AU4328800A (en) Pharmaceutical formulation
AU3374799A (en) Delivery of an angiogenic substance
AU2498100A (en) Use of an amiodarone compound as antifungal agent
AU5975700A (en) Nasal formulation of an antifungal
AU1026901A (en) Novel herbicides
AU1174801A (en) Humidifier
AU2982000A (en) Preparation of 9-hydrocarbyl-9-phosphabicyclononanes
AUPQ066399A0 (en) Antifungal combination use
AU3969300A (en) Coating device
AU2007401A (en) Pest control agent/pf 1022-221
AU3839900A (en) Pharmaceutical formulation
AU7711800A (en) Novel uses of 2-bromopalmitate
AU1388501A (en) Pharmaceutical formulation
AU5276300A (en) Taccalonolide microtubule stabilizing agents
AU4592900A (en) Herbicides
AU3175500A (en) Insecticide formulation

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase